Healthcare provider profile · identity verified

Vaibhavkumar Vachhani, MD

Internal Medicine · DURHAM, NC · NPI 1780016758

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	465	144
Atorvastatin Calcium	Atorvastatin Calcium	455	143
Hydrochlorothiazide	Hydrochlorothiazide	318	102
Levothyroxine Sodium	Levothyroxine Sodium	290	83
Omeprazole	Omeprazole	235	71
Metoprolol Succinate	Metoprolol Succinate	234	69
Gabapentin	Gabapentin	232	60
Losartan Potassium	Losartan Potassium	223	70
Pantoprazole Sodium	Pantoprazole Sodium	223	78
Alprazolam	Alprazolam	222	49
Furosemide	Furosemide	181	63
Tamsulosin Hcl	Tamsulosin Hcl	178	59
Lisinopril	Lisinopril	159	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	156	29
Metformin Hcl	Metformin Hcl	152	45
Rosuvastatin Calcium	Rosuvastatin Calcium	151	52
Eliquis	Apixaban	142	35
Sertraline Hcl	Sertraline Hcl	139	41
Zolpidem Tartrate	Zolpidem Tartrate	116	32
Simvastatin	Simvastatin	113	35
Trazodone Hcl	Trazodone Hcl	112	29
Potassium Chloride	Potassium Chloride	110	26
Glimepiride	Glimepiride	107	29
Lorazepam	Lorazepam	104	25
Clonazepam	Clonazepam	102	24
Escitalopram Oxalate	Escitalopram Oxalate	101	33
Enalapril Maleate	Enalapril Maleate	99	26
Prednisone	Prednisone	97	44
Metformin Hcl Er	Metformin Hcl	95	29
Metoprolol Tartrate	Metoprolol Tartrate	90	30
Allopurinol	Allopurinol	89	28
Azithromycin	Azithromycin	81	64
Ezetimibe	Ezetimibe	80	24
Mirtazapine	Mirtazapine	80	15
Clopidogrel	Clopidogrel Bisulfate	79	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	79	29
Carvedilol	Carvedilol	78	23
Meloxicam	Meloxicam	78	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	15
Fluticasone Propionate	Fluticasone Propionate	68	27
Albuterol Sulfate Hfa	Albuterol Sulfate	65	35
Atenolol	Atenolol	65	16
Famotidine	Famotidine	65	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	64	21
Spironolactone	Spironolactone	63	21
Tramadol Hcl	Tramadol Hcl	63	20
Oxycodone Hcl	Oxycodone Hcl	59	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	16
Glipizide	Glipizide	57	17
Lovastatin	Lovastatin	51	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	14
Diazepam	Diazepam	45	12
Montelukast Sodium	Montelukast Sodium	45	16
Finasteride	Finasteride	44	14
Glipizide Er	Glipizide	43	12
Bupropion Xl	Bupropion Hcl	42	12
Duloxetine Hcl	Duloxetine Hcl	42	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	suppressed
Donepezil Hcl	Donepezil Hcl	40	15
Esomeprazole Magnesium	Esomeprazole Magnesium	40	suppressed
Valsartan	Valsartan	39	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	27
Ozempic	Semaglutide	37	suppressed
Colchicine	Colchicine	35	suppressed
Cefuroxime	Cefuroxime Axetil	34	29
Jardiance	Empagliflozin	34	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	28
Linzess	Linaclotide	32	suppressed
Meclizine Hcl	Meclizine Hcl	32	14
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Ibandronate Sodium	Ibandronate Sodium	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	12
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Ondansetron Odt	Ondansetron	26	14
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	18
Pregabalin	Pregabalin	23	12
Telmisartan	Telmisartan	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	12
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Cephalexin	Cephalexin	22	22
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Ramipril	Ramipril	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Nabumetone	Nabumetone	19	suppressed
Nystatin	Nystatin	19	11
Premarin	Estrogens, Conjugated	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	17
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Nitroglycerin	Nitroglycerin	17	13
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Fluconazole	Fluconazole	15	13
Folic Acid	Folic Acid	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lactulose	Lactulose	15	suppressed
Metronidazole	Metronidazole	15	13
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Olanzapine Odt	Olanzapine	14	suppressed
Topiramate	Topiramate	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Baclofen	Baclofen	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Singulair	Montelukast Sodium	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error